Suppr超能文献

芬太尼的强制降解:杂质和降解产物的鉴定与分析。

Forced degradation of fentanyl: identification and analysis of impurities and degradants.

机构信息

Analytical Research and Development, Alexza Pharmaceuticals, 2091 Stierlin Court, Mountain View, CA 94043, United States.

出版信息

J Pharm Biomed Anal. 2010 Nov 2;53(3):325-34. doi: 10.1016/j.jpba.2010.04.004. Epub 2010 Apr 13.

Abstract

Fentanyl, N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide is a rapid-acting, powerful opioid analgesic used extensively for anesthesia and chronic pain management. A forced degradation study of fentanyl active pharmaceutical ingredient (API) was performed using light, acid, base, heat and oxidation. Under acidic conditions, fentanyl was shown to degrade to N-phenyl-1-(2-phenylethyl)-piperidin-4-amine (PPA(1)). Fentanyl was stable to light exposure and base treatment with no degradation observed. Oxidation with hydrogen peroxide produced fentanyl N-oxide by rapidly oxidizing the nitrogen on the piperidine ring. Five degradants were formed during thermal degradation of fentanyl. The two known degradants included propionanilide (PRP(2)) and norfentanyl (NRF(3)). The three unknown degradants were first identified by mass using LC/MS, and postulated compounds were synthesized and confirmed by LC/MS and (1)H NMR. These degradants were identified as 1-phenethylpyridinium salt (1-PEP(4)), 1-phenethyl-1H-pyridin-2-one (1-PPO(5)), and 1-styryl-1H-pyridin-2-one (1-SPO(6)). In addition to the seven degradants, three known process impurities, acetyl fentanyl, pyruvyl fentanyl and butyryl fentanyl were also detected by reverse-phase high performance liquid chromatography (HPLC) with UV detection. All degradants and impurities were identified and confirmed using authentic materials. Method validation was performed for the assay of fentanyl and its related compounds in accordance to ICH guideline Q2(R1), and the method was demonstrated to be specific, linear (r>0.999 for fentanyl assay and r>0.996 for related compounds), accurate (recovery>99.6% for fentanyl assay and recovery>91.0 for related compounds), precise (%RSD<0.8% for fentanyl assay and <4.8% for related compounds), sensitive (limit of detection=0.08 microg/mL or 0.016% of nominal concentration), robust and suitable for its intended use. The chemical structures for the degradants and impurities were submitted to three in silico toxicity programs to identify any structural alerts.

摘要

芬太尼,N-(1-苯乙基哌啶-4-基)-N-苯基丙酰胺,是一种快速起效、强效的阿片类镇痛药,广泛用于麻醉和慢性疼痛管理。对芬太尼原料药(API)进行了强制降解研究,使用了光、酸、碱、热和氧化。在酸性条件下,芬太尼被证明会降解为 N-苯基-1-(2-苯乙基)-哌啶-4-胺(PPA(1))。芬太尼对光照和碱处理稳定,未观察到降解。用过氧化氢氧化迅速氧化哌啶环上的氮,生成芬太尼 N-氧化物。在芬太尼的热降解过程中形成了五种降解产物。两种已知的降解产物包括丙酰苯胺(PRP(2))和去甲芬太尼(NRF(3))。通过 LC/MS 首次鉴定了三种未知的降解产物,并通过 LC/MS 和 (1)H NMR 合成并确证了推测的化合物。这些降解产物被鉴定为 1-苯乙基吡啶鎓盐(1-PEP(4))、1-苯乙基-1H-吡啶-2-酮(1-PPO(5))和 1-苯乙烯基-1H-吡啶-2-酮(1-SPO(6))。除了七种降解产物外,还通过反相高效液相色谱(HPLC)和紫外检测检测到三种已知的工艺杂质,乙酰芬太尼、丙酰芬太尼和丁酰芬太尼。所有降解产物和杂质均通过对照品进行了鉴定和确认。按照 ICH 指南 Q2(R1) 进行了芬太尼及其相关化合物的含量测定方法验证,该方法被证明具有专属性、线性(芬太尼测定的 r>0.999,相关化合物的 r>0.996)、准确性(芬太尼测定的回收率>99.6%,相关化合物的回收率>91.0%)、精密度(芬太尼测定的 RSD<0.8%,相关化合物的 RSD<4.8%)、灵敏度(检测限=0.08 microg/mL 或名义浓度的 0.016%)、稳健性和适用性。降解产物和杂质的化学结构被提交给三个计算机毒性程序,以识别任何结构警报。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验